Hana Mekonnen

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms

James A. Simon, David Portman, Andrew M. Kaunitz et al. · Menopause The Journal of The North American Menopause Society · 2013 · 144 citations

Medicine, Pharmacology, Pharmacotherapy +16

PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection

Kush Dhody, Nader Pourhassan, Kazem Kazempour et al. · HIV Clinical Trials · 2018 · 50 citations

Pharmacy, Pharmacotherapy, Molecular Virology +16

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

JoAnn V. Pinkerton, Hadine Joffe, Kazem Kazempour et al. · Menopause The Journal of The North American Menopause Society · 2014 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

David Portman, Andrew M. Kaunitz, Kazem Kazempour et al. · Menopause The Journal of The North American Menopause Society · 2014 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17